Print Page     Close Window     

SEC Filings

424B3
BIOTIME INC filed this Form 424B3 on 02/04/2019
Entire Document
 
 

 

BIOTIME ADJOURNMENT PROPOSAL

 

If BioTime fails to receive a sufficient number of votes to approve the BioTime Share Issuance Proposal, BioTime may propose to adjourn the BioTime Special Meeting, if a quorum is present, for a period of not more than 45 days for the purpose of soliciting additional proxies to approve the BioTime Share Issuance Proposal. BioTime currently does not intend to propose adjournment at the BioTime Special Meeting if there are sufficient votes to approve the BioTime Share Issuance Proposal.

 

Vote Required; Recommendation of the BioTime Board

 

Approval of the BioTime Adjournment Proposal requires the affirmative vote of a majority of the voting power of the shares present in person or represented by proxy at the meeting and entitled to vote on the proposal. If you are a BioTime shareholder and fail to vote or fail to instruct your broker or nominee to vote, it will have no effect on the BioTime Adjournment Proposal, assuming a quorum is present; however, if you vote to abstain, it will have the same effect as a vote against the BioTime Adjournment Proposal.

 

The BioTime Board recommends that BioTime shareholders vote “FOR” the BioTime Adjournment Proposal.

 

108

© Copyright BioTime, Inc.